Putnam BioRevolution ETF (SYNB) Holdings $25.56 -1.52 (-5.61%) Closing price 04:10 PM EasternExtended Trading$25.64 +0.08 (+0.31%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsRatingsBuy This Stock Top 37 SYNB HoldingsRankCompanyCurrent PriceWeightShares Held1TMOThermo Fisher Scientific$437.71-6.9%8.48%8262ABBVAbbVie$186.58-7.5%5.74%1,4163CTVACorteva$55.66-9.2%5.29%4,3324BIOBio-Rad Laboratories$225.21-4.1%5.24%1,0185NVZMYNovozymes A/S$60.91-0.1%4.84%4,1406LLYEli Lilly and Company$737.56-6.5%4.45%2497AZNAstraZeneca$68.46-7.4%4.35%2,9438ASNDAscendis Pharma A/S$142.67-4.9%4.15%1,3659NVDANVIDIA$94.31-7.4%4.10%1,69210GOOGLAlphabet$145.60-3.4%3.96%1,200 Get the Latest News and Ratings for SYNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11REGNRegeneron Pharmaceuticals$573.45-6.1%3.88%28612DDDuPont de Nemours$58.96-13.0%3.78%2,38213Net CashN/A3.07%158,25814CDNSCadence Design Systems$232.88-6.4%2.95%60715AVTRAvantor$15.15-3.4%2.81%8,66916DARDarling Ingredients$29.21-7.2%2.75%3,93017NGVTIngevity$31.37-9.5%2.53%2,73818ICLRICON Public$153.72-6.0%2.38%64519DHRDanaher$181.42-8.3%2.33%57820Symrise AGN/A2.02%1,03521ONONON$39.56+5.1%1.95%2,07822Borregaard ASAN/A1.71%5,33023ARGXargenx$555.11-5.9%1.68%13924BMRNBioMarin Pharmaceutical$60.26-10.7%1.68%1,21625Danone Sedol B1y9tb3N/A1.61%1,16126PPGPPG Industries$98.98-4.8%1.58%72027VRTXVertex Pharmaceuticals$474.62-1.9%1.55%16728TECHBio-Techne$51.72-5.7%1.33%1,11329ZTSZoetis$151.76-4.9%1.12%34630BIIBBiogen$122.98-5.9%1.11%40631ALNYAlnylam Pharmaceuticals$235.74-10.1%1.07%22432EXASExact Sciences$42.55-3.9%0.95%1,03633TWSTTwist Bioscience$36.19-3.5%0.95%1,26034BGBunge Global$73.30-6.3%0.93%64935LEGNLegend Biotech$32.01-2.6%0.64%94236RCKTRocket Pharmaceuticals$5.12-7.9%0.62%3,40037CRSPCRISPR Therapeutics$32.650.0%0.40%468 Geographic ExposureUnited States78.6%France2.8%Ireland2.2%Germany2.2%Norway1.8%Switzerland1.4%Currency ExposureUSD71.2%EUR5.0%NOK1.8%Sector ExposureHealth Care47.8%Materials22.1%Technology7.1%Communications3.9%Consumer Staples2.7%Financials1.8%Industry ExposureBiotechnology32.9%Chemicals22.1%Health Care Equipment & Supplies9.8%Media3.9%Semiconductors & Semiconductor Equipment3.8%Software3.3%Life Sciences Tools & Services2.9%Food Products2.7%Health Care Providers & Services2.2%Banks1.8%SubIndustry ExposureBiotechnology31.2%Specialty Chemicals16.4%Life Sciences Tools & Services12.7%Fertilizers & Agricultural Che5.7%Interactive Media & Services3.9%Semiconductors3.8%Application Software3.3%Agricultural Products2.7%Health Care Services2.2%Diversified Banks1.8% Related Companies and Tools Related Companies ProShares Nanotechnology ETF Portfolio Global X Disruptive Materials ETF Portfolio KraneShares Dynamic Emerging Markets Strategy ETF Portfolio Macquarie Global Listed Infrastructure ETF Portfolio iShares Environmental Infrastructure and Industrials ETF Portfolio Avantis Inflation Focused Equity ETF Portfolio Cboe Vest 10 Year Interest Rate Hedge ETF Portfolio Global X Solar ETF Portfolio ProShares Metaverse ETF Portfolio NYLI Clean Oceans ETF Portfolio This page (NYSEARCA:SYNB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
